JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marcoli, M.
Right arrow Articles by Maura, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marcoli, M.
Right arrow Articles by Maura, G.

Vol. 299, Issue 3, 1106-1111, December 2001

Inhibitory Presynaptic 5-Hydroxytryptamine2A Receptors Regulate Evoked Glutamate Release from Rat Cerebellar Mossy Fibers

Manuela Marcoli, Christian Rosu, Andrea Bonfanti, Maurizio Raiteri and Guido Maura

Dipartimento di Medicina Sperimentale, Sezione di Farmacologia e Tossicologia, Università di Genova, Genova, Italy

We studied the pharmacological characterization of the 5-hydroxytryptamine2 (5-HT2) heteroreceptor located on glutamatergic cerebellar mossy fiber nerve terminals. Depolarization-evoked overflow of endogenous glutamate from rat cerebellar "giant" mossy fiber synaptosomes was inhibited by 5-HT or (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)-DOI], exhibiting pD2 (= -log EC50) values of 7.37 and 7.29, respectively. Trazodone inhibited the depolarization-evoked glutamate overflow, exhibiting lower potency (pD2 = 6.42) and lower efficacy with respect to 5-HT or (±)-DOI (maximal inhibition, 54%, compared with 70% for either 5-HT or (±)-DOI). Ketanserin, a 5-HT2A/5-HT2C receptor antagonist, counteracted the inhibitory effect of (±)-DOI or trazodone. Inhibition of glutamate overflow by 5-HT, (±)-DOI, or trazodone was prevented by the selective 5-HT2A receptor antagonist R-(+)-alpha -(2,3-dimethyoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidine-methanol (MDL 100907), while the potent and selective 5-HT2C receptor antagonist 6-chloro-5-methyl-1-[6-(methylpyridin-3-yloxy)pyridin-3yl-carbamoyl] indoline (SB 242084) was ineffective. In cerebellar slices, MDL 100907 increased on its own the K+-evoked release of glutamate. It is concluded that the evoked release of glutamate from cerebellar mossy fibers can be controlled by inhibitory presynaptic 5-HT2A heteroreceptors, the receptors can be activated by endogenously released 5-HT, and trazodone behaves as a partial agonist at these receptors.


0022-3565/01/2993-1106$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Papageorgiou and C. Denef
Stimulation of Growth Hormone Release by 5-Hydroxytryptamine (5-HT) in Cultured Rat Anterior Pituitary Cell Aggregates: Evidence for Mediation by 5-HT2B, 5-HT7, 5-HT1B, and Ketanserin-Sensitive Receptors
Endocrinology, September 1, 2007; 148(9): 4509 - 4522.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.